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"Somehow our devils are never quite what we expect when we meet them face to face".  Nelson 
DeMille.
"The mind can cook up very subtle syndromes to throw at our bodies".   Astrid Alauda.
The varying clinical presentations of not so well recognized diseases, which continue to haunt 
patients is well described in the above quotes. Clinicians may not recognize associated subtle early 
presentations of the disease, till the disease has fully manifested itself. Of all the disorders of 
human body, autonomic syndromes are still the least understood. Presentation and association of 
autonomic diseases with other disorders may be so varied and subtle that clinicians may fail to 
recognize autonomic disturbance as an individual clinical entity within the disease and therefore 
appropriate management still remains inadequate. Similar association between joint hypermobility 
disorder, in which postural orthostatic tachycardia syndrome and dysautonomia is increasingly 
being recognized as an associated clinical entity, has been further elaborated.                           
Postural   orthostatic   tachycardia   syndrome   (POTS)   is   a   form   of   dysautonomia   affecting 
predominantly young females, consisting of a constellation of symptoms with symptomatic 
orthostatic intolerance and by definition, a change from supine to an upright position causes an 
increase in heart rate of more than 30 beats per minute or to a heart rate greater than 120 beats per 
minute within 10 minutes of upright position [1-3]. Tachycardia is often accompanied by a mild 
decrease   in   blood   pressure   as   well.   Sympathetic   overactivity   causing   tachycardia,   mild 
hypotension, autonomic dysfunction, brain and other organ hypoperfusion may cause a range of 
symptoms. Symptoms may range from mild and occasional complaints to severely incapacitating 
disease and are commonly misdiagnosed as having chronic anxiety or panic disorder or chronic 
fatigue syndrome [3,4]. POTS is often accompanied by vasovagal syncope [2-4].                    
Primary POTS is related to partial dysautonomia and hyperadrenergic state [2]. The cause of 
primary POTS is not fully known. Reduced venous return during standing due to venous pooling 
or denervation causing low plasma volume may be responsible for a hyperadrenergic state 
resulting as the body attempts to compensate for these abnormalities. Family history of orthostatic 
intolerance suggests a genetic predisposition [5]. Adrenergic receptor dysfunction [6] with alpha 1 
and   beta   receptor   supersensitivity,   hyperdopaminergic   state   [7]   and   high   free   plasma 
norepinephrine levels have all been described with POTS. Precipitating physical or mental stress 
can trigger symptoms and disease which may thereafter persist for long [2,3].                           
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 10 (4): 158-161 (2010)Shomu Bohora, “Joint Hypermobility Syndrome and Dysautonomia:                        159 
Expanding Spectrum of Disease Presentation and Manifestation”
Secondary POTS is due to peripheral autonomic denervation. Commonly associated conditions 
are diabetes mellitus, amyloidosis, sarcoidosis, alcoholism, lupus, heavy metal intoxication, 
Sjogren's syndrome and post-chemotherapy. Pure dysautonomic syndromes due to sympathetic 
under-activity may have POTS as a presenting feature. POTS has also been associated with 
musculoskeletal disorders like Ehlers-Danlos syndrome, Marfans syndrome, fibromyalgia and 
joint hypermobility syndrome.                                                                                     
Joint Hypermobility syndrome (JHS) was first described by Kirk et al in 1967 to describe a 
disorder of generalized joint hypermobility and musculoskeletal pain [8]. The term benign has 
been used in order to distinguish this symptomatic, but not life threatening, disorder from diseases 
such as Marfans and Ehlers-Danlos syndrome.  The prevalence of joint hypermobility varies from 
10-30% and decreases with age [9-12]. Generalized hypermobility is thought to be a disorder of 
collagen that contributes to a loss of tensile strength and consequent increased fragility of 
involved tissues. As far as etiology of JHS is concerned, genetic predisposition (polygenic trait) is 
the most likely cause [13,14]. Also mutations in the TNXB gene have been associated with 
hypermobility [15,16]. In addition to the skin and musculoskeletal manifestations, mitral valve 
prolapse [17,18] and autonomic symptoms [19-22] are commonly seen. Surprisingly a large 
proportion of patients have significant neuromuscular and motor development problems in 
association   with   JHS   [23].                                                                              
In the current issue of this journal Kanjwal et al [24] have described clinical profile of patients 
having POTS with and without JHS.  In this retrospective study, they showed that patients with 
JHS and POTS appear to become symptomatic much earlier and have significantly higher 
incidence of syncope and migraine than the non JHS counterparts. Increase in joint laxity causing 
increased   venous   pooling   with   secondary   hyperadrenergic   state   or   receptor   dysregulation 
predisposing to autonomic dysregulation has been postulated to be a cause of the increased 
association of POTS and syncope with JHS and abnormal vascular reactivity within the cerebral 
vasculature for migraine association with JHS [25-29]. There are no studies to suggest primary 
affection of the nervous system in JHS presently, though nearly 70% of patients of JHS may 
suffer from some form of dysautonomia related symptoms [2]. Based on the present study by 
Kanjwal et al [24], it may be appropriate that all young patients who present with symptoms of 
migraine or syncope, who have symptoms and orthostatic stress suggesting POTS should also be 
screened for hypermobility of joints and for JHS. In future dysautonomia related symptoms 
possibly would be considered for diagnosis of JHS in addition to the present revised Brighton 
diagnostic criteria for JHS which incorporates only musculoskeletal criteria for diagnosis of the 
condition [30].                                                                                                                                 
There still remain some unanswered, but important, questions. How exactly are JHS and POTS 
associated? Why do both POTS and JHS have female preponderance? Is it related to genetic, 
hormonal or environmental modification of the nervous system along with differences in 
musculoskeletal structure in patients that predispose to the above or is there a single cause of all 
these contiguous syndromes which we are yet to discover? Based on what was remarkably said by 
Charles Dickens "Oh the nerves, the nerves; the mysteries of this machine called man!  Oh the 
little that unhinges it, poor creatures that we are!" we possibly would continue to recognize new 
syndromes of dysautonomia and its associations with various clinical entities out of this machine 
called man.                                                                                                                         
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